Investigation of Hospital-Onset Methicillin-Resistant Staphylococcus aureus Bloodstream Infections at Eight High Burden Acute Care Facilities in the United States, 2016
- PMID: 32283173
- PMCID: PMC7857529
- DOI: 10.1016/j.jhin.2020.04.007
Investigation of Hospital-Onset Methicillin-Resistant Staphylococcus aureus Bloodstream Infections at Eight High Burden Acute Care Facilities in the United States, 2016
Abstract
Background: Despite large reductions from 2005-2012, hospital-onset methicillin-resistant Staphylococcus aureus bloodstream infections (HO MRSA BSIs) continue be a major source of morbidity and mortality.
Aim: To describe risk factors for and underlying sources of HO MRSA BSIs.
Methods: We investigated HO MRSA BSIs at eight high-burden short-stay acute care hospitals. A case was defined as first isolation of MRSA from a blood specimen collected in 2016 on hospital day ≥4 from a patient without an MRSA-positive blood culture in the 14 days prior. We reviewed case-patient demographics and risk factors by medical record abstraction. The potential clinical source(s) of infection were determined by consensus by a clinician panel.
Findings: Of the 195 eligible cases, 186 were investigated. Case-patients were predominantly male (63%); median age was 57 years (range 0-92). In the two weeks prior to the BSI, 88% of case-patients had indwelling devices, 31% underwent a surgical procedure, and 18% underwent dialysis. The most common locations of attribution were intensive care units (ICUs) (46%) and step-down units (19%). The most commonly identified non-mutually exclusive clinical sources were CVCs (46%), non-surgical wounds (17%), surgical site infections (16%), non-ventilator healthcare-associated pneumonia (13%), and ventilator-associated pneumonia (11%).
Conclusions: Device-and procedure-related infections were common sources of HO MRSA BSIs. Prevention strategies focused on improving adherence to existing prevention bundles for device-and procedure-associated infections and on source control for ICU patients, patients with certain indwelling devices, and patients undergoing certain high-risk surgeries are being pursued to decrease HO MRSA BSI burden at these facilities.
Keywords: Bloodstream infection (BSI); Healthcare-associated infections (HAIs); Methicillin-Resistant Staphylococcus aureus (MRSA).
Copyright © 2020. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest The authors have no conflicts of interest and no financial interests to disclose. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.JAMA. 2009 Feb 18;301(7):727-36. doi: 10.1001/jama.2009.153. JAMA. 2009. PMID: 19224749
-
Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea.Infect Control Hosp Epidemiol. 2009 Feb;30(2):146-55. doi: 10.1086/593953. Infect Control Hosp Epidemiol. 2009. PMID: 19128184
-
Evolving Epidemiology of Staphylococcus aureus Bacteremia.Infect Control Hosp Epidemiol. 2015 Dec;36(12):1417-22. doi: 10.1017/ice.2015.213. Epub 2015 Sep 16. Infect Control Hosp Epidemiol. 2015. PMID: 26372679
-
Methicillin-resistant Staphylococcus aureus in Intensive Care Unit Setting of India: A Review of Clinical Burden, Patterns of Prevalence, Preventive Measures, and Future Strategies.Indian J Crit Care Med. 2020 Jan;24(1):55-62. doi: 10.5005/jp-journals-10071-23337. Indian J Crit Care Med. 2020. PMID: 32148350 Free PMC article. Review.
-
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future.Expert Opin Drug Saf. 2024 Jan;23(1):9-36. doi: 10.1080/14740338.2023.2299377. Epub 2023 Dec 29. Expert Opin Drug Saf. 2024. PMID: 38145925 Review.
Cited by
-
Trends of Bloodstream Infections in a University Hospital During 12 Years.Pol J Microbiol. 2022 Sep 24;71(3):443-452. doi: 10.33073/pjm-2022-039. eCollection 2022 Sep 1. Pol J Microbiol. 2022. PMID: 36185018 Free PMC article.
-
Classical and alternative disinfection strategies to control the COVID-19 virus in healthcare facilities: a review.Environ Chem Lett. 2021;19(3):1945-1951. doi: 10.1007/s10311-021-01180-4. Epub 2021 Jan 22. Environ Chem Lett. 2021. PMID: 33500689 Free PMC article. Review.
-
Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis.Emerg Microbes Infect. 2022 Dec;11(1):443-451. doi: 10.1080/22221751.2022.2030196. Emerg Microbes Infect. 2022. PMID: 35034585 Free PMC article.
References
-
- Centers for Disease Control and Prevention. 2018. National state and healthcare-associated infections progress report. Atlanta, GA: CDC; 2018. Available at: https://www.cdc.gov/hai/data/portal/progress-report.html [last accessed April 2020].
-
- Srinivasan A, Wise M, Bell M, Cardo D, Edwards J, Fridkin S, et al. Vital signs: central line-associated blood stream infections – United States, 2001, 2008, 2009. Morb Mortal Wkly Rep 2011;60:243–8. - PubMed
-
- Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997–2007. JAMA 2009;301:727–36. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources